Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Placental expression of vimentin, desmin and ultrastructural changes in the villi in patients with HELLP syndrome.

Sak ME, Deveci E, Turgut A, Sak S, Evsen MS, Gul T, Kalkanli S.

Eur Rev Med Pharmacol Sci. 2013 Apr;17(7):874-8.

2.
3.

Human placental macrophages (Hofbauer cells) in severe preeclampsia complicated by HELLP syndrome: immunohistochemistry of chorionic villi.

Evsen MS, Kalkanli S, Deveci E, Sak ME, Ozler A, Baran O, Erdem E, Seker U.

Anal Quant Cytopathol Histpathol. 2013 Oct;35(5):283-8.

PMID:
24282909
4.

Placental syncytiotrophoblast maintains a specific type of glycocalyx at the fetomaternal border: the glycocalyx at the fetomaternal interface in healthy women and patients with HELLP syndrome.

Hofmann-Kiefer KF, Chappell D, Knabl J, Frank HG, Martinoff N, Conzen P, Becker BF, Rehm M.

Reprod Sci. 2013 Oct;20(10):1237-45. doi: 10.1177/1933719113483011. Epub 2013 Apr 12.

PMID:
23585336
5.
6.

Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.

Fruscalzo A, Schmitz R, Klockenbusch W, Köhler G, Londero AP, Siwetz M, Huppertz B.

Histochem Cell Biol. 2012 Dec;138(6):925-32. doi: 10.1007/s00418-012-0997-1. Epub 2012 Jul 31.

PMID:
22847813
7.

Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.

Stepan H, Leo C, Purz S, Höckel M, Horn LC.

Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):172-6.

PMID:
16219518
8.

Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.

Jeschke U, Mayr D, Schiessl B, Mylonas I, Schulze S, Kuhn C, Friese K, Walzel H.

Placenta. 2007 Nov-Dec;28(11-12):1165-73. Epub 2007 Jul 30.

PMID:
17664004
9.

Placental expression of endothelial and inducible nitric oxide synthase and nitric oxide levels in patients with HELLP syndrome.

Mazzanti L, Cecati M, Vignini A, D'Eusanio S, Emanuelli M, Giannubilo SR, Saccucci F, Tranquilli AL.

Am J Obstet Gynecol. 2011 Sep;205(3):236.e1-7. doi: 10.1016/j.ajog.2011.04.022. Epub 2011 Apr 16.

PMID:
21700268
10.

Expression of the blood-group-related antigens Sialyl Lewis a, Sialyl Lewis x and Lewis y in term placentas of normal, preeclampsia, IUGR- and HELLP-complicated pregnancies.

Minas V, Mylonas I, Schiessl B, Mayr D, Schulze S, Friese K, Jeschke U, Makrigiannakis A.

Histochem Cell Biol. 2007 Jul;128(1):55-63. Epub 2007 Jun 6.

PMID:
17551747
11.

Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome.

Knerr I, Dachert C, Beinder E, Metzler M, Dötsch J, Repp R, Rascher W.

Eur J Obstet Gynecol Reprod Biol. 2002 Feb 10;101(1):47-53.

PMID:
11905404
12.

Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.

Várkonyi T, Nagy B, Füle T, Tarca AL, Karászi K, Schönléber J, Hupuczi P, Mihalik N, Kovalszky I, Rigó J Jr, Meiri H, Papp Z, Romero R, Than NG.

Placenta. 2011 Feb;32 Suppl:S21-9. doi: 10.1016/j.placenta.2010.04.014. Epub 2010 Jun 11.

13.

Immunohistological study in cases of HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) and acute fatty liver of pregnancy.

Halim A, Kanayama N, El Maradny E, Maehara K, Takahashi A, Nosaka K, Fukuo S, Amamiya A, Kobayashi T, Terao T.

Gynecol Obstet Invest. 1996;41(2):106-12.

PMID:
8838970
14.

Expression of inflammatory cytokines in placentas from pregnancies complicated with preeclampsia and HELLP syndrome.

Marusic J, Prusac IK, Tomas SZ, Karara JR, Roje D.

J Matern Fetal Neonatal Med. 2013 May;26(7):680-5. doi: 10.3109/14767058.2012.746301. Epub 2012 Dec 14.

PMID:
23131093
15.

Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.

Szabo S, Mody M, Romero R, Xu Y, Karaszi K, Mihalik N, Xu Z, Bhatti G, Fule T, Hupuczi P, Krenacs T, Rigo J Jr, Tarca AL, Hassan SS, Chaiworapongsa T, Kovalszky I, Papp Z, Than NG.

Pathol Oncol Res. 2015 Jul;21(3):659-68. doi: 10.1007/s12253-014-9872-9. Epub 2015 Jan 13.

PMID:
25583406
16.
17.

Severe preeclampsia with and without HELLP differ with regard to placental pathology.

Vinnars MT, Wijnaendts LC, Westgren M, Bolte AC, Papadogiannakis N, Nasiell J.

Hypertension. 2008 May;51(5):1295-9. doi: 10.1161/HYPERTENSIONAHA.107.104844. Epub 2008 Mar 24. Erratum in: Hypertension. 2014 Apr;63(4):e90.

18.

Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome.

Tranquilli AL, Landi B, Corradetti A, Giannubilo SR, Sartini D, Pozzi V, Emanuelli M.

Cytokine. 2007 Nov;40(2):82-8. Epub 2007 Oct 4.

PMID:
17919920
19.

Seven placental transcripts characterize HELLP-syndrome.

Buimer M, Keijser R, Jebbink JM, Wehkamp D, van Kampen AH, Boer K, van der Post JA, Ris-Stalpers C.

Placenta. 2008 May;29(5):444-53. doi: 10.1016/j.placenta.2008.02.007.

PMID:
18374411
20.

Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.

Szabo S, Xu Y, Romero R, Fule T, Karaszi K, Bhatti G, Varkonyi T, Varkonyi I, Krenacs T, Dong Z, Tarca AL, Chaiworapongsa T, Hassan SS, Papp Z, Kovalszky I, Than NG.

Virchows Arch. 2013 Sep;463(3):445-58. doi: 10.1007/s00428-013-1426-0. Epub 2013 Jun 27.

Supplemental Content

Support Center